idursulfase

Trials studying idursulfase

• phase3A Phase III Study of JR-141 in Patients With Mucopolysaccharidosis II (STARLIGHT)active not recruitingn=86
• —Post-trial Access Program of Idursulfase-IT Along With Elaprase in Children With Hunter Syndromeavailable
• phase4Long-term Evaluation on Height and Weight in Patients With MPS II Who Started Treatment at < 6 Years of Agecompletedn=21
• phase4A Study of ELAPRASE in Treatment-naïve Participants With Hunter Syndrome (Mucopolysaccharidosis [MPS] II)withdrawn
• phase3Extension Study of Idursulfase-IT Along With Elaprase in Children and Adults With Hunter Syndrome and Cognitive Impairmentactive not recruitingn=6
• phase2An Extension Study of HGT-HIT-045 Evaluating Long-Term Safety and Clinical Outcomes of Idursulfase-IT in Conjunction With Elaprase in Pediatric Participants With Hunter Syndrome and Cognitive Impairmentcompletedn=15
• phase3A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric and Young Adult Participants With Neuronopathic (nMPS II) or Non-Neuronopathic Mucopolysaccharidosis Type II (nnMPS II)recruitingn=63
• phase3Study of Long Term Safety and Clinical Outcomes of Idursulfase IT and Elaprase Treatment in Pediatric Participants Who Have Completed Study HGT-HIT-094completedn=56